Peritoneal dialysis and inflammation.

@article{Velloso2014PeritonealDA,
  title={Peritoneal dialysis and inflammation.},
  author={Marina Souza Silva Velloso and Alba Otoni and Adriano de Paula Sabino and Whocely Victor de Castro and S{\'e}rgio Wyton Lima Pinto and Maria Aparecida Silva Marinho and Danyelle Romana Alves Rios},
  journal={Clinica chimica acta; international journal of clinical chemistry},
  year={2014},
  volume={430},
  pages={109-14}
}
Peritoneal dialysis (PD) is a kidney replacement therapy for end stage renal disease (ESRD) patients. Despite being a lifesaving treatment, the rate of mortality in patients under PD is elevated, mainly due to the chronic peritoneal dysfunction which is characterized by inflammation, peritoneal fibrosis and neoangiogenesis. The inflammatory process is trigged and modulated by the type of the peritoneal dialysis solutions (PDSs) used during PD. Currently, different PDSs are commercially… CONTINUE READING